The CA Supreme Court determined that trial courts lack authority to strike claims brought under CA’s PAGA on grounds that trying them is unmanageable.

Reverse mergers have helped biotech companies access public markets, but recent SEC positions are threatening that path to going public.

The U.S. Supreme Court declined to review a district court decision upholding the validity and enforceability of a judgment-sharing agreement.

The new Gen AI Policy Builder makes it easy for a company to create a comprehensive internal policy to govern current and future use of Gen AI tools.

In the eighteenth instalment of Orrick's Founder Series, we will discuss what you need to know and what to do to get the most out of your cap table.